Search
for
Sort by
Research 151–180 of 166
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis
- Sinergitas Efek Kombinasi Ekstrak Daun SirsaK (Annona muricata Linn) Dengan Doksorubisin Pada Sel Kanker Payudara MCF-7
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- The possibilities of correction of premature greying of hair and involutive hair changes
- Ayurveda & Bioactives as Adjuvant for Dna Modulation in Cancer Treatment & Adverse Drug Reaction [ADR] – A Glimpse of Traditional Indian Nanotechnology
- Research Progress of Extracellular Vesicles-Loaded Microneedle Technology
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Protective Effect of Iris germanica L. Rhizome-Derived Exosome against Oxidative-Stress-Induced Cellular Senescence in Human Epidermal Keratinocytes
- Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
- Long non-coding RNA AL136131.3 inhibits hair growth through mediating PPARγ in androgenetic alopecia
- Azole Antifungal–Induced Erythema Annulare Centrifugum in a Case of Extensive Tinea
- New frontiers in CRISPR/Cas9 delivery systems delivery for gene editing
- Menstrual Irregularities in Adolescent Girls and Correlation with the Extent of Exposure to Plastics: A Case-Control Study
- Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
- Is knowledge about the genetic and epigenetic alterations in melanoma a basis for targeted therapy?
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Hand-Foot and Stump Syndrome to Sorafenib
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Sorafenib-induced eruption resembling pityriasis rubra pilaris
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Sorafenib-Associated Facial Acneiform Eruption
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Sorafenib stimulates human skin type mast cell degranulation and maturation
- Delayed onset perforating folliculitis associated with sorafenib